Schrödinger, a global leader in computational chemistry, uses the Sapio laboratory informatics platform to enhance its proprietary in silico discovery workflows and accelerate drug development. With about 900 employees worldwide, the company applies its physics‑based technology to design novel, high‑quality molecules across materials science and life sciences. Sapio’s platform supports end‑to‑end data management, extending Schrödinger’s capabilities from plasmid design through structural analysis. This integration enables more efficient research, streamlined workflows, and faster progression of both materials breakthroughs like OLEDs and advanced drug discovery programs.

Join for free to read